← All Sponsors
SPONSOR

Dogwood Therapeutics Inc.

Total Trials
1
Recruiting
1
Phases
Phase 2
Conditions studied: Chemotherapy Induced Neuropathic Pain
NCT06848348 Phase 2
Recruiting

Efficacy and Safety Study of Halneuron in the Treatment of Chemotherapy-Induced Neuropathic Pain

Chemotherapy Induced Neuropathic Pain
United States View Trial →